The use of blood flow modifiers to improve the treatment response of solid tumors.
There is now considerable interest in the possible use of agents which can change blood flow in solid tumors and thereby alter the response of tumors to different treatments. In the current presentation we briefly review the types of agents which have the potential to modify tumor blood flow, using nicotinamide. hydralazine, and pyrazinamide as examples and illustrate how they can be used to improve the response of murine tumors to radiation, hyperthermia and cyclophosphamide.
Horsman
M R
MR
Danish Cancer Society, Department of Experimental Clinical Oncology, Aarhus.
Chaplin
D J
DJ
Overgaard
J
J
D000818:Animals; D003131:Combined Modality Therapy; D006830:Hydralazine / Q000627:therapeutic use*; D051379:Mice; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000628:therapy*; D009536:Niacinamide / Q000627:therapeutic use*; D011718:Pyrazinamide / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects* / Q000528:radiation effects
D009536:Niacinamide; D006830:Hydralazine; D011718:Pyrazinamide